KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Inventory Average (2016 - 2025)

Historic Inventory Average for Vertex Pharmaceuticals (VRTX) over the last 15 years, with Q4 2025 value amounting to $1.7 billion.

  • Vertex Pharmaceuticals' Inventory Average rose 4500.26% to $1.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.7 billion, marking a year-over-year increase of 4500.26%. This contributed to the annual value of $1.4 billion for FY2025, which is 4876.04% up from last year.
  • Latest data reveals that Vertex Pharmaceuticals reported Inventory Average of $1.7 billion as of Q4 2025, which was up 4500.26% from $1.6 billion recorded in Q3 2025.
  • In the past 5 years, Vertex Pharmaceuticals' Inventory Average ranged from a high of $1.7 billion in Q4 2025 and a low of $289.8 million during Q1 2021
  • In the last 5 years, Vertex Pharmaceuticals' Inventory Average had a median value of $607.7 million in 2023 and averaged $745.6 million.
  • Its Inventory Average has fluctuated over the past 5 years, first soared by 1387.9% in 2022, then surged by 7094.85% in 2023.
  • Over the past 5 years, Vertex Pharmaceuticals' Inventory Average (Quarter) stood at $343.3 million in 2021, then rose by 23.63% to $424.4 million in 2022, then soared by 68.18% to $713.8 million in 2023, then soared by 60.08% to $1.1 billion in 2024, then soared by 45.0% to $1.7 billion in 2025.
  • Its last three reported values are $1.7 billion in Q4 2025, $1.6 billion for Q3 2025, and $1.4 billion during Q2 2025.